{"nct_id":"NCT01809210","title":"Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer","status":"COMPLETED","status_verified_date":"2018-03","start_date":"2013-04-04","start_date_type":"ACTUAL","primary_completion_date":"2016-01-04","primary_completion_date_type":"ACTUAL","completion_date":"2016-01-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AZN"]}